 Nemaura Medical, Inc. NASDAQ: NMRD Nemaura or the Company, a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, its non-invasive and flexible continuous glucose monitor CGM, today announced that it has commissioned the integration of data from third party wearable devices into its proBEATTM app which is planned for launch in the USA later this year. 